BioOra brings life-changing cell therapies closer to global commercial success
Seeking investors
We’re currently seeking capital
There is increasing global demand for life-changing CAR T-cell therapies. Existing manufacturing processes can’t keep up: they’re labour-intensive and costs are prohibitive.
By automating the manufacture of cutting-edge CAR T-cell therapies, we can accelerate the pace from clinical trial to commercial reality without compromising efficacy, safety and quality.
Alongside our partners, we combine advanced manufacturing technologies with world-class clinical models of care to reach launch faster.
Funds raised will be used to:
Complete the current CAR T-cell clinical trial with our partner, the Malaghan Institute of Medical Research
Continue development of our closed manufacturing platform
Build New Zealand’s first CAR T-cell manufacturing facility